Table 3.
Anticancer drugs target DDX5/17 to inhibit tumor progression.
| Anticancer drugs | Targeting DDX | Cancer types | References |
|---|---|---|---|
| Simvastatin | DDX5 | Renal cell carcinoma | (153) |
| Resveratrol | DDX5 | Prostate cancer | (136) |
| DRD2 | DDX5 | Breast cancer | (154) |
| 2F5 | DDX5 | Acute promyelocytic leukemia | (144) |
| Endoxifen/Fulvestrant | DDX5/17 | Breast cancer | (155) |
| RX-5902 | DDX5 | Triple-negative breast cancer | (156–158) |